ArticlePharmaceutics2022

Preclinical Therapeutic Assessment of a New Chemotherapeutics [Dichloro(4,4'-Bis(2,2,3,3-Tetrafluoropropoxy) Methyl)-2,2'-Bipryridine) Platinum] in an Orthotopic Patient-Derived Xenograft Model of Triple-Negative Breast Cancers.

Tzu-Chun Kan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.